Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05066009 · ClinicalTrials.gov registry record · NA

Sleep/Wake State Assessment with Non-invasive Earbuds

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
8
Enrollment target

NCT05066009 is a NA study that has completed, run by Emory University. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05066009, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

This study is a within subject's assessment of whether a novel wearable technology, NextSense electroencephalography earbuds (EEGBuds), is able to detect differences in onset to sleep from wake versus in-laboratory, gold-standard electroencephalography (EEG) utilized as part of a standard four trial Maintenance of Wakefulness Test (MWT) at medicated baseline versus free of prescribed medications for promoting wake (random order).

Interventions

  • DEVICE NextSense EEG-enabled earbuds
  • DEVICE Ellcie Healthy eyeglasses
  • OTHER Drug Holiday

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2021-10-13
Est. Completion 2023-10-27
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT05066009

The ClinicalTrials.gov registry entry for NCT05066009 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which NextSense EEG-enabled earbuds is the first listed.

NCT05066009 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05066009 about?

NCT05066009 is a clinical study titled "Sleep/Wake State Assessment with Non-invasive Earbuds". This study is a within subject's assessment of whether a novel wearable technology, NextSense electroencephalography earbuds (EEGBuds), is able to detect differences in onset to sleep from wake versus in-laboratory, gold-standard electroencephalography (EEG) utilized as part of a standard four trial...

What is the current status of trial NCT05066009?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-10-13. Estimated completion is 2023-10-27.

What interventions are being tested in trial NCT05066009?

The interventions under investigation include: NextSense EEG-enabled earbuds (DEVICE), Ellcie Healthy eyeglasses (DEVICE), Drug Holiday (OTHER).

Who is sponsoring clinical trial NCT05066009?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.